GlobeImmune, Inc. (OTCMKTS:GBIM – Get Free Report)’s share price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. GlobeImmune shares last traded at $0.00, with a volume of 13,249 shares traded.
GlobeImmune Stock Performance
GlobeImmune Company Profile
GlobeImmune, Inc, a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy.
Recommended Stories
- Five stocks we like better than GlobeImmune
- The Risks of Owning Bonds
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Election Stocks: How Elections Affect the Stock Market
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to trade using analyst ratings
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for GlobeImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlobeImmune and related companies with MarketBeat.com's FREE daily email newsletter.
